Jian Ding1, Carley Tasker, Pierre Lespinasse, Jihong Dai, Patricia Fitzgerald-Bocarsly, Wuyuan Lu, Debra Heller, Theresa Li-Yun Chang. 1. *Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ; Departments of †Microbiology and Molecular Genetics; ‡Obstetrics, Gynecology and Women's Health; §Pathology and Laboratory Medicine, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ; and ‖Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: CD4 T cells are crucial for the establishment and dissemination of HIV in mucosal tissues during acute infection. Studies indicate that integrin α4β7 CD4 T cells are preferentially infected by HIV in vitro and during acute SIV infection. The integrin α4β7 is thought to promote HIV capture by target cells; however, the role of integrin α4β7 in HIV transmission remains controversial. In this study, we characterized immune phenotypes of human cervical T cells and examined HIV preference in integrin α4β7 CD4 T cells. In vitro all-trans retinoic acid-differentiated peripheral CD4 T cells (atRA-differentiated cells) were included as a comparison. RESULTS: In both peripheral and cervical cells, the majority of HIV p24 cells were activated CD4 T cells expressing integrin α4β7. Among infected atRA-differentiated cells, the frequency of CCR5 expression was higher in HIV p24 cells than in HIV p24 cells; no such difference was observed in cervical cells. Neither the cyclic hexapeptide CWLDVC nor a monoclonal antibody against integrin α4β7 blocked HIV attachment or gp120 binding to target cells regardless of the presence of CD4, indicating that integrin α4β7 did not facilitate HIV capture by target cells. CONCLUSIONS: Integrin α4β7 expression increases HIV susceptibility, but the mechanism is not through promoting HIV binding to target cells.
BACKGROUND:CD4 T cells are crucial for the establishment and dissemination of HIV in mucosal tissues during acute infection. Studies indicate that integrin α4β7 CD4 T cells are preferentially infected by HIV in vitro and during acute SIV infection. The integrin α4β7 is thought to promote HIV capture by target cells; however, the role of integrin α4β7 in HIV transmission remains controversial. In this study, we characterized immune phenotypes of human cervical T cells and examined HIV preference in integrin α4β7 CD4 T cells. In vitro all-transretinoic acid-differentiated peripheral CD4 T cells (atRA-differentiated cells) were included as a comparison. RESULTS: In both peripheral and cervical cells, the majority of HIV p24 cells were activated CD4 T cells expressing integrin α4β7. Among infected atRA-differentiated cells, the frequency of CCR5 expression was higher in HIV p24 cells than in HIV p24 cells; no such difference was observed in cervical cells. Neither the cyclic hexapeptide CWLDVC nor a monoclonal antibody against integrin α4β7 blocked HIV attachment or gp120 binding to target cells regardless of the presence of CD4, indicating that integrin α4β7 did not facilitate HIV capture by target cells. CONCLUSIONS: Integrin α4β7 expression increases HIV susceptibility, but the mechanism is not through promoting HIV binding to target cells.
Authors: R Krzysiek; A Rudent; L Bouchet-Delbos; A Foussat; C Boutillon; A Portier; D Ingrand; D Sereni; P Galanaud; L Grangeot-Keros; D Emilie Journal: Blood Date: 2001-11-15 Impact factor: 22.113
Authors: Nicholas F Parrish; Craig B Wilen; Lauren B Banks; Shilpa S Iyer; Jennifer M Pfaff; Jesus F Salazar-Gonzalez; Maria G Salazar; Julie M Decker; Erica H Parrish; Anna Berg; Jennifer Hopper; Bhavna Hora; Amit Kumar; Tatenda Mahlokozera; Sally Yuan; Charl Coleman; Marion Vermeulen; Haitao Ding; Christina Ochsenbauer; John C Tilton; Sallie R Permar; John C Kappes; Michael R Betts; Michael P Busch; Feng Gao; David Montefiori; Barton F Haynes; George M Shaw; Beatrice H Hahn; Robert W Doms Journal: PLoS Pathog Date: 2012-05-31 Impact factor: 6.823
Authors: Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek Journal: J Exp Med Date: 2004-09-13 Impact factor: 14.307
Authors: Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast Journal: AIDS Patient Care STDS Date: 2016-07 Impact factor: 5.078
Authors: Elizabeth J McFarland; Tina M Powell; Carolyne Onyango-Makumbi; Weiming Zhang; Kelsey Melander; Prossy Naluyima; Samuel Okurut; Michael A Eller; Mary Glenn Fowler; Edward N Janoff Journal: J Infect Dis Date: 2017-02-01 Impact factor: 5.226
Authors: Anusmita Sahoo; Andrew T Jones; Narayanaiah Cheedarla; Sailaja Gangadhara; Vicky Roy; Tiffany M Styles; Ayalnesh Shiferaw; Korey L Walter; LaTonya D Williams; Xiaoying Shen; Gabriel Ozorowski; Wen-Hsin Lee; Samantha Burton; Lasanajak Yi; Xuezheng Song; Zhaohui S Qin; Cynthia A Derdeyn; Andrew B Ward; John D Clements; Raghavan Varadarajan; Georgia D Tomaras; Pamela A Kozlowski; Galit Alter; Rama Rao Amara Journal: Sci Immunol Date: 2022-07-22
Authors: Alicia R Berard; Charlene Miller; Mariluz Araínga; Courtney Ann Broedlow; Laura Noël-Romas; Luca Schifanella; Tiffany Hensley-McBain; Alex Roederer; Connor B Driscoll; Ernesto Coronado; Jennifer Manuzak; Lyle R McKinnon; Francois Villinger; Thomas J Hope; Adam D Burgener; Nichole R Klatt Journal: AIDS Res Hum Retroviruses Date: 2021-06-22 Impact factor: 1.723
Authors: Mathieu Uzzan; Minami Tokuyama; Adam K Rosenstein; Costin Tomescu; Ivo N SahBandar; Huaibin M Ko; Louise Leyre; Anupa Chokola; Emma Kaplan-Lewis; Gabriela Rodriguez; Akihiro Seki; Michael J Corley; Judith Aberg; Annalena La Porte; Eun-Young Park; Hideki Ueno; Ioannis Oikonomou; Itai Doron; Iliyan D Iliev; Benjamin K Chen; Jennifer Lui; Timothy W Schacker; Glaucia C Furtado; Sergio A Lira; Jean-Frederic Colombel; Amir Horowitz; Jean K Lim; Nicolas Chomont; Adeeb H Rahman; Luis J Montaner; Lishomwa C Ndhlovu; Saurabh Mehandru Journal: Sci Transl Med Date: 2018-10-03 Impact factor: 17.956